Novartis AG agreed to buy US biotech Anthos Therapeutics for as much as $3.1 billion to gain a preventative stroke medicine ...

Novartis is expanding its prospects in cardiometabolic ... Anthos already has clinical trial results topping Xarelto. A Phase 2 test of abelacimab was stopped early in 2023 due to “overwhelming ...

RxTechExam and the Pennsylvania Pharmacists Association announced a strategic partnership. Roche’s $8 billion InterMune acquisition has been handed to a specialty pharmaceutical company, Cayman ...

In this week's InnovationRx newsletter, federal judges halt Trump's cuts to NIH research payments, rural hospitals' ongoing ...

Novartis AG agreed to buy US biotech Anthos Therapeutics for as much as $3.1 billion to gain a preventative stroke medicine ...

Comedian Wanda Sykes is raising breast cancer awareness in a new commercial airing on Superbowl Sunday. After Sykes was ...

This article discusses the Anti-Kickback Statute and the False Claims Act. "When coupled with the False Claims Act (FCA), the AKS turns into a potent civil enforcement tool that carries many of the ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...

Yuhan Corporation announced on the 11th that the allergy drug candidate "YH35324," introduced from GI Innovation, has demonstrated superior therapeutic effects compared to Novartis' "Xolair ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...

Think of your loved ones — your family, friends, people you work with, or even the people in your community. Can you name ...